Let's not forget that the enterprise products take much longer to deploy and therefore take much longer to recognise as revenue on LVT's books.
If you read the latest customer story on their website, Walsall Healthcare NHS Trust -- a new customer who came onboard last year as a result of covid -- they're still in the process of implementing their full enterprise solution. However their Reach solution is already live, due to it's much faster deployment time. They started engaging with the customer on this project back in November, as evidenced by this post below.
This is likely to be a very common theme across all new LVT customer deployments. So it's reasonable to conclude that the smaller 14% growth in non-Reach products could be a result of this lag in deployment time, not just from lower demand.
LVT Price at posting:
13.0¢ Sentiment: Buy Disclosure: Held
(20min delay)